PPARG and colitis: Of importance, thiazolidinediones still improve colitis severity incolonic epithelium-specific PPARγ−/− mice,but not in macrophage-specific PPARγ−/− mice,suggesting that macrophages are the relevant targets of these compounds in thisdisease [63].